Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Clinical Therapeutics|September 4, 2013
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial)Kevin C Maki, David G Orloff, Stephen J Nicholls, et al.Case Reports in Endocrinology|April 16, 2020
Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous <i>APOC2</i> MutationMasako Ueda, Anna Wolska, Frances M Burke, et al.Journal of Lipid Research|January 26, 2017
Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimeticsRichard L Dunbar, Harsh Goel, Sony Tuteja, et al.The American Journal of Medicine|July 31, 2012
Extended-release niacin acutely suppresses postprandial triglyceridemiaM Haris U Usman, Arman Qamar, Ramprasad Gadi, et al.Circulation|June 28, 2019
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in HypertriglyceridemiaZahid Ahmad, Poulabi Banerjee, Sara Hamon, et al.Journal of Clinical Lipidology|September 26, 2020
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patientsAnne C Goldberg, Richard L Dunbar, Linda Hemphill, et al.Diabetes Care|June 9, 2016
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 DiabetesAndres Digenio, Richard L Dunbar, Veronica J Alexander, et al.The American Journal of Medicine|April 3, 2016
Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGHRonald B Goldberg, Vera A Bittner, Richard L Dunbar, et al.Journal of the American Heart Association|February 19, 2025
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized TrialRahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg, et al.Academic Radiology|February 25, 2015
A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomographyEmil M deGoma, Ali Salavati, Russell T Shinohara, et al.Pageof 4